Attached files
| file | filename |
|---|---|
| EX-99.01 - EX-99.01 - ESCALON MEDICAL CORP | exhibit1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | September 28, 2010 |
Escalon Medical Corp.
__________________________________________
(Exact name of registrant as specified in its charter)
| Pennsylvania | 000-20127 | 330272839 |
|
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 435 Devon Park Drive, Building 100, Wayne, Pennsylvania | 19087 | |
|
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
| Registrant’s telephone number, including area code: | 610-688-6830 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On September 28, 2010, Escalon Medical Corp issued a press release announcing its financial results for the year ended June 30, 2010, a copy of which is attached hereto as Exhibit 99.1 and incorporated in this Item 2.02 by reference.
Item 9.01 Financial Statements and Exhibits.
Exhibits
99.1 Press Release dated September 28, 2010
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Escalon Medical Corp. | ||||
| September 28, 2010 | By: |
Ricahrd J. DePiano, Jr
|
||
|
|
||||
| Name: Ricahrd J. DePiano, Jr | ||||
| Title: President & GC | ||||
Exhibit Index
| Exhibit No. | Description | |
|
|
|
|
|
99.01
|
Press Release dated September 28, 2010 |